Physiochemical properties of low and high molecular weight poly(ethylene glycol)-grafted poly(ethylene imine) copolymers and their complexes with oligonucleotides

Biomacromolecules

Volumn 7, Issue 1, 2006, Pages 347-356

  Glodde, Martin ^a   Sirsi, Shashank R ^a   Lutz, Gordon J ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; COMPLEXATION; GRAFTING (CHEMICAL); MOLECULAR STRUCTURE; OLIGOMERS; PHYSICAL PROPERTIES; POLYETHYLENE GLYCOLS; SURFACE PROPERTIES; SYNTHESIS (CHEMICAL);

BUFFERING CAPACITY; LOW MOLECULAR WEIGHT POLYETHYLENE GLYCOL; OLIGONUCLEOTIDES; PARTICLE AGGREGATION; PHYSICOCHEMICAL PROPERTIES; POLYETHYLENE IMINE;

COPOLYMERS;

ANTISENSE OLIGONUCLEOTIDE; BUFFER; COPOLYMER; HEPARIN; MACROGOL; MACROGOL DERIVATIVE; POLY(ETHYLENE IMINE); POLYANION; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GENETIC TRANSFECTION; MOLECULAR SIZE; MOLECULAR STABILITY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; PH MEASUREMENT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SURFACE CHARGE; SYNTHESIS;

ANIMALS; ANIONS; BUFFERS; CHEMISTRY, PHYSICAL; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; OLIGONUCLEOTIDES; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; TRANSFECTION; WATER;

ANIMALIA;

EID: 31544468071     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm050726t     Document Type: Article

References (43)

1. Shi, F.; Hoekstra, D. Effective intracellular delivery of oligonucleotides in order to make sense of antisense. J. Controlled Release 2004, 97 (2), 189-209.
2. Kurreck, J. Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem. 2003, 270 (8), 1628-1644.
3. Marcusson, E. G.; Yacyshyn, B. R.; Shanahan, W. R., Jr.; Dean, N. M. Preclinical and clinical pharmacology of antisense oligonucleotides. Mol. Biotechnol. 1999, 12 (1), 1-11.
4. Ravichandran, L. V.; Dean, N. M.; Marcusson, E. G. Use of antisense oligonucleotides in functional genomics and target validation. Oligonucleotides 2004, 14 (1), 49-64.
5. Opalinska, J. B.; Gewirtz, A. M. Nucleic-acid therapeutics: basic principles and recent applications. Nat. Rev. Drug Discovery 2002, 1 (7), 503-514.
6. Goodchild, J. Oligonucleotide therapeutics: 25 years agrowing. Curr. Opin. Mol. Ther. 2004, 6 (2), 120-128.
7. Dias, N.; Stein, C. A. Antisense oligonucleotides: basic concepts and mechanisms. Mol. Cancer Ther. 2002, 1 (5), 347-355.
8. Sazani, P.; Kole, R. Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. J. Clin. Invest. 2003, 112 (4), 481-486.
9. van Deutekom, J. C. Gene Therapy: The 'pro-sense' approach to Duchenne muscular dystrophy. Eur. J. Hum. Genet. 2005, 13 (5), 518-519.
10. Bremmer-Bout, M.; Aartsma-Rus, A.; de Meijer, E. J.; Kaman, W. E.; Janson, A. A.; Vossen, R. H.; van Ommen, G. J.; den Dunnen, J. T.; van Deutekom, J. C. Targeted exon skipping in transgenic hDMD mice: A model for direct preclinical screening of human-specific antisense oligonucleotides. Mol. Ther. 2004, 10 (2), 232-240.
11. Wiethoff, C. M.; Middaugh, C. R. Barriers to nonviral gene delivery. J. Pharm. Sci. 2003, 92 (2), 203-217.
12. Hughes, M. D.; Hussain, M.; Nawaz, Q.; Sayyed, P.; Akhtar, S. The cellular delivery of antisense oligonucleotides and ribozymes. Drug Discovery Today 2001, 6 (6), 303-315.
13. Merdan, T.; Kopecek, J.; Kissel, T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug Delivery Rev. 2002, 54 (5), 715-758.
14. Roth, C. M.; Sundaram, S. Engineering synthetic vectors for improved DNA delivery: insights from intracellular pathways. Annu. Rev. Biomed. Eng. 2004, 6, 397-426.
15. Dass, C. R. Vehicles for oligonucleotide delivery to tumours. J. Pharm. Pharmacol. 2002, 54 (1), 3-27.
16. Brazas, R. M.; Hagstrom, J. E. Delivery of small interfering RNA to mammalian cells in culture by using cationic lipid/polymer-based transfection reagents. Methods Enzymol. 2005, 392, 112-124.
17. Ulrich, A. S. Biophysical aspects of using liposomes as delivery vehicles. Biosci. Rep. 2002, 22 (2), 129-150.
18. Semple, S. C.; Harasym, T. O.; Clow, K. A.; Ansell, S. M.; Klimuk, S. K.; Hope, M. J. Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid. J. Pharmacol. Exp. Ther. 2005, 312 (3), 1020-1026.
19. Bieber, T.; Meissner, W.; Kostin, S.; Niemann, A.; Elsasser, H. P. Intracellular route and transcriptional competence of polyethylenimine-DNA complexes. J. Controlled Release 2002, 82 (2-3), 441-454.
20. Suh, J.; Wirtz, D.; Hanes, J. Efficient active transport of gene nanocarriers to the cell nucleus. Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (7), 3878-3882.
21. Petersen, H.; Fechner, P. M.; Fischer, D.; Kissel, T. Synthesis, Characterization, and Biocompatibility of Polyethylenimine-graft-poly(ethylene glycol) Block Copolymers. Macromolecules 2002, 35, 6867-6874.
22. Petersen, H.; Fechner, P. M.; Martin, A. L.; Kunath, K.; Stolnik, S.; Roberts, C. J.; Fischer, D.; Davies, M. C.; Kissel, T. Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjugate Chem. 2002, 13 (4), 845-854.
23. Kichler, A. Gene transfer with modified polyethylenimines. J. Gene Med. 2004, 6 (Suppl. 1), S3-10.
24. Thomas, M.; Klibanov, A. M. Non-viral gene therapy: polycation-mediated DNA delivery. Appl. Microbiol. Biotechnol. 2003, 62 (1), 27-34.
25. Sonawane, N. D.; Szoka, F. C., Jr.; Verkman, A. S. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. Biol. Chem. 2003, 278 (45), 44826-44831.
26. Akinc, A.; Thomas, M.; Klibanov, A. M.; Langer, R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J. Gene Med. 2005, 7 (5), 657-663.
27. Kunath, K.; von, H. A.; Petersen, H.; Fischer, D.; Voigt, K.; Kissel, T.; Bickel, U. The structure of PEG-modified poly(ethylene imines) influences biodistribution and pharmacokinetics of their complexes with NF-kappaB decoy in mice. Pharm. Res. 2002, 19 (6), 810-817.
28. Brus, C.; Petersen, H.; Aigner, A.; Czubayko, F.; Kissel, T. Physicochemical and biological characterization of polyethylenimine-graft-poly(ethylene glycol) block copolymers as a delivery system for oligonucleotides and ribozymes. Bioconjugate Chem. 2004, 15 (4), 677-684.
29. Schiffelers, R. M.; Ansari, A.; Xu, J.; Zhou, Q.; Tang, Q.; Storm, G.; Molema, G.; Lu, P. Y.; Scaria, P. V.; Woodle, M. C. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 2004, 32 (19), e149.
30. Fischer, D.; Osburg, B.; Petersen, H.; Kissel, T.; Bickel, U. Effect of poly(ethylene imine) molecular weight and pegylation on organ distribution and pharmacokinetics of polyplexes with oligodeoxynucleotides in mice. Drug Metab. Dispos. 2004, 32 (9), 983-992.
31. Vinogradov, S. V.; Batrakova, E. V.; Kabanov, A. V. Nanogels for oligonucleotide delivery to the brain. Bioconjugate Chem. 2004, 15 (1), 50-60.
32. Jeong, J. H.; Kim, S. W.; Park, T. G. A new antisense oligonucleotide delivery system based on self-assembled ODN-PEG hybrid conjugate micelles. J. Controlled Release 2003, 93 (2), 183-191.
33. Vinogradov, S. V.; Bronich, T. K.; Kabanov, A. V. Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides. Bioconjugate Chem. 1998, 9 (6), 805-812.
34. Vinogradov, S.; Batrakova, E.; Li, S.; Kabanov, A. Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells. Bioconjugate Chem. 1999, 10 (5), 851-860.
35. Kunath, K.; von Harpe, A.; Fischer, D.; Petersen, H.; Bickel, U.; Voigt, K.; Kissel, T. Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J. Controlled Release 2003, 89 (1), 113-125.
36. Morrison, I. D.; Grabowski, E. F.; Herb, C. A. Improved Techniques for Particle Size Determination by Quasi-Elastic Light Scattering. Langmuir 1985, 1, 496-501.
37. Nguyen, H. K.; Lemieux, P.; Vinogradov, S. V.; Gebhart, C. L.; Guerin, N.; Paradis, G.; Bronich, T. K.; Alakhov, V. Y.; Kabanov, A. V. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther. 2000, 7 (2), 126-138.
38. Benns, J. M.; Mahato, R. L; Kim, S. W. Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine. J. Controlled Release 2002, 79 (1-3), 255-269.
39. Von Harpe, A.; Petersen, H.; Li, Y.; Kissel, T. Characterization of commercially available and synthesized polyethylenimines for gene delivery. J. Controlled Release 2000, 69 (2), 309-322.
40. Ruponen, M.; Ronkko, S.; Honkakoski, P.; Pelkonen, J.; Tammi, M.; Urtti, A. Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes. J. Biol. Chem. 2001, 276 (36), 33875-33880.
41. Van Rompaey, E.; Engelborghs, Y.; Sanders, N.; De Smedt, S. C.; Demeester, J. Interactions between oligonucleotides and cationic polymers investigated by fluorescence correlation spectroscopy. Pharm. Res. 2001, 18 (7), 928-936.
42. Jones, N. A.; Hill, I. R.; Stolnik, S.; Bignotti, F.; Davis, S. S.; Garnett, M. C. Polymer chemical structure is a key determinant of physicochemical and colloidal properties of polymer-DNA complexes for gene delivery. Biochim. Biophys. Acta 2000, 1517 (1), 1-18.
43. Sirsi, S. R.; Williams, J.; Lutz, G. J. Poly(ethylene imine)-Polyethylene Glycol Copolymers Facilitate Efficient Delivery of Antisense Oligonucleotides to Nuclei of Mature Muscle Cells of mdx Mice. Hum. Gene Ther. 2005, 16 (11), 1307-1317.